Peaches Biotech Group
IN THE SERVICE OF HEALTH AND BIOTECHNOLOGY
Peaches Biotech
Peaches Biotech Group works to transfer the most relevant advances in science and health technology to the citizens, in order to contribute to the development and welfare of society.
What we include
The Peaches Group is made up of professionals and companies involved in science, technology and innovation in health, collaborating with various foundations and research groups, one of which is the University Hospital of Fuenlabrada, where it is present with the Bioincubator of companies specializing in Advanced Cell Therapy; Living Cells, a pioneering agreement in Spain for public-private collaboration.
Management team
The Peaches Biotech team is formed by different multidisciplinary professionals linked to science and technology in health.
Ignacio Vega
President of Cardiva and Cardivais
Read more
Ignacio Vega is a member of the Board of Directors of Grupo Peaches.
He began his professional career in the healthcare technology sector at Medtronic in 1977. Curiosity and a background in economics led him to found MedTech in 1982. Subsequently, in 1988, he launched Cardiva and, in 2002, Cardivais. More than three decades later, work continues to define his life, always from a conscious and humane perspective. Perseverance, confidence in the team and the desire to excel have marked his career. He is also a member of the Board of Directors of iVascular and Histocell.
Francesca Sarno
Directora científica de Peaches Biotech
Read more
She holds a Ph.D. in Biology from the Complutense University of Madrid, with training in the fields of genetics and molecular biology. She has experience managing competitive national and international projects.
She is currently the scientific director of the Peaches group. She is responsible for the planning, management, and execution of clinical trials in the field of advanced therapies, biological products, and secretomes.
Juan Carlos de Gregorio
CEO of Peaches Biotech Group
Read more
Degree in Pharmacy (Specialization in Food Technology and Enzymology and Industrial Galenics), Executive M.B.A. (IESE) and professor at the Official College of Pharmacists of Madrid.
With more than 30 years of experience in pharmaceuticals, biotechnology, biomedicine and healthcare, as well as extensive experience as an entrepreneur, with strong leadership and team skills.
In 2005, he received the IESE-Vocento- Ernst&Young Innovation Award.
He was also Founder and CEO of Exxentia, a company that became a leader in Europe in the sale of raw materials for the production of medicinal plants, basing its success on research, being integrated into Puleva Biotech in 2008, with De Gregorio joining the Management Committee of the Ebro – Puleva Group.
At Grupo Andrómaco he was Technical Pharmaceutical Director and Director of Marketing.
Our companies
We work to transfer the most relevant advances in health science and technology to citizens, in order to contribute to the development and welfare of society.
Living Cells
Lyposmol Biotech
At the service of health and biotechnology
Always within the framework of innovation and the latest medical and scientific technologies that bring quality of life to people.
SCIENCE
TECHNOLOGY
LOCATION
6 Isabel Colbrand St.,
, 4th Floor, Suite B,
, 28050 Madrid (Spain)
Openinig Hours
M – Th : 9 :00-18:00 hs
F : 9 :00-15:00 hs
